Fever in immunocompromised patients

New England Journal of Medicine

Volumn 341, Issue 12, 1999, Pages 893-900

  Pizzo, Philip A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL INFECTION; EARLY DIAGNOSIS; FEVER; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; NEUTROPENIA; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPLENECTOMY; TRANSPLANTATION; VIRUS INFECTION;

EID: 0033575990     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199909163411207     Document Type: Article

References (32)

1. Freifeld AG, Walsh TJ, Pizzo PA. Infections in the cancer patient. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997:2659-704.
2. Pizzo PA. The compromised host. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil textbook of medicine. 20th ed. Philadelphia: W.B. Saunders (in press).
3. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
4. Mackowiak PA, Bartlett JG, Borden EC, et al. Concepts of fever: recent advances and lingering dogma. Clin Infect Dis 1997;35:119-38.
5. Gerard C. Bacterial infection: for whom the bell tolls. Nature 1998;395: 217-9.
6. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
7. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
8. Lehrnbecher T, Foster C, Vazquez N, Mackall CL, Chanock SJ. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 1997;19:399-417.
9. Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992;71:24-43.
10. Mayo J, Collazos J, Martinez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scand J Infect Dis 1997; 29:327-36.
11. Bissuel F, Leport C, Perronne C, Longuet P, Vilde JL. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 1994;236:529-35.
12. Miralles P, Moreno S, Perez-Tascon M, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995;20:872-5.
13. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997;160:91-102.
14. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-51.
15. Avery RK. Infectious disease and transplantation: messages for the generalist. Cleve Clin J Med 1998;65:305-14.
16. Green M, Michaels MG. Infectious complications of solid-organ transplantation in children. Adv Pediatr Infect Dis 1992;7:181-204.
17. Koll BS, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993;17:Suppl 2:S322-S328.
18. Aquino VM, Pappo A, Buchanan GR, Tkaczewski I, Mustafa MM. The changing epidemiology of bactcremia in neutropenic children with cancer. Pediatr Infect Dis J 1995;14:140-3.
19. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992;11:287-91.
20. Wilfert CM. Invasive bacterial infections in children with HIV infection. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. 3rd ed. Baltimore: Williams & Wilkins, 1998:117-25.
21. Roilides E, Butler KM, Husson RN, Mueller BU, Lewis LL, Pizzo PA. Pseudomonas infections in children with human immunodeficiency virus. Pediatr Infect Dis J 1992;11:547-53.
22. Kieff E. Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome. In: First National AIDS Malignancy Conference. Journal of the National Cancer Institute monographs. No. 23. Washington, D.C.: Government Printing Office, 1998:7-14.
23. Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998;92:1549-55.
24. Lewis LL, Butler KM, Husson RN, et al. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr 1992;121:677-83.
25. Hughes WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-73.
26. Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552-8.
27. Sanders JW, Powe NR, Moore RD. Ccftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis. J Infect Dis 1991;164:907-16.
28. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994;120:834-44.
29. Freifeld AG, Walsh T, Marshall D, et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995;13:165-76.
30. Rubenstein EB, Rolston K, Benjamin RS, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993;71:3640-6.
31. Malik IA, Khan WA, Karim M, Aziz Z, Khan MA. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995;98:224-31.
32. Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341:305-11.